After the initial reaction they got when they announced the sucess against breast cancer its hard to believe they would change to blood bourn cancer for commercial reaons. We were originally discussing the need for the treatment to be iv injectable to be seriously commercial i think. When we consider the sink effect of the human body absorbing the cpps before they get the chance to reach the deeper target cells then it makes perfect sense why they switched to blood cancers. It seems sometimes unfortunate that some cancers appear more attractive to target than others, and i would think breast or lung cancer are among the most high profile, yet the switch to me at least confirms that they realise any sucess will come through injectable treatment and with cpp and injection and half life etc the best target is the first thing you hit ie blood. Good they can change and adapt, bad that this was a surprise after starting with breast cancer. Either way as long as they cure something i guess we are good. Just got to get the first cpp onto approved medicine next.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)